Anti-arrhythmics - Elam Flashcards
Which drugs cause torsade? What is it?
- Torsade: polymorphic vtach initiated by early after-depolarization (EAD) in setting of prolonged QT (i.e., prolonged phase 2 and 3 repolarization of AP)
- Seen with (drugs with class III activity):
1. K+ channel blocking antiarrhythmics (class III); rarely with Amiodarone
2. Tricyclic anti-depressants (Imiprimine)
3. Na+ channel blockers (Procaine, Quin)
4. Non-sedating anti-histamines (Terfenidine withdrawn from market) - Exacerbated by hypokalemia, low HR
- Initiated by a triggered VPC from an EAD and leading to re-entry
Describe the normal automaticity of the pacemaker cells.
- SA, atrial, AV, ventricular conducting fibers spontaneously depolarize (pacemaker activity)
- Pacemaker currents mediated by activation of inward Na+/K+ pacemaker (hyperpolarization or funny) channel
- SA, AV node: depolarization results in opening of inward Ca channels (L-type)
- Atrial, ventricular fibers depolarization mediated by inward Na channel
Flecainide (Class IC)
- Action: long-acting Na+ blocker (>10s); suppresses automaticity, INC ERP in atria, ventricles
-
Use: SV arrhythmias (afib, aflutter, SVT) and NO structural heart disease
1. Contraindicated in pts w/structural heart disease (pro-arrhythmic in CHD, LV dysfunction)
2. May be used in young people to treat congenital causes of afib or flutter (after trying everything else)
Dronedarone
- Non-iodinated congener of Amiodarone approved for tx of paroxysmal atrial fibrillation or maintenance of sinus rhythm following cardioversion
- Contraindicated in patients with decompensated CHF
How do class I antiarrhythmics suppress arrhythmias?
- Suppress ectopic pacemakers and interrupt re-entry by blocking Na+ channels
- Phase 0 depolarization slowed -> slowed conduction and suppressed ectopic pacemakers
- Reduced availability of Na+ channels INC mem voltage required for new depolarization -> INC refractory period
- Depolarization sodium-dependent in atrial/ventricular myocytes
Vtach long-term tx. EF 30% 4 months after tx, so high-risk for sudden cardiac death due to vtach or vfib.
Treatment?
- Implantable defibrillator (no dosing concerns)
- Could give Amiodarone or Sotalol if defibrillator was not an option for some reason
Dofetilide/Ibutilide
- Pure class III (no activity from other classes) anti-arrhythmics primarily used to tx atrial arrhythmias
-
Dofetilide: used to interrupt re-entry in the atrium
1. Major AE: polymorphic vtach (torsade)
2. Contraindication: pts with long QT interval -
Ibutilide: IV only for acute termination of atrial flutter or fibrillation
1. Torsade de pointes in 3-8% of pts
Digoxin
- Antiarrhythmic effects mediated via INC vagal N activity:
1. Reduces SA node automaticity, AV conduction
2. Controls ventricular rate in SV arrhythmias
3. Interrupts re-entry in AV node - Direct effect (arrhythmogenic): INC normal automaticity, delayed afterdepolarizations (DAD; APC, VPC), paroxysmal atrial tachycardia with block, vtach (Na/K ATPase inhibition with Ca overload)
Beta-blockers (Class II)
- Block/slow AV node, slowing HR in SV arrhythmias
1. Metoprolol, Esmolol - Suppress ventricular premature beats (VPB’s) related to SYM activity
1. Propranolol, Acebutolol - Rate control in atrial flutter/fibrillation; prevents recurrence of PSVT
1. Atenolol - Remember: beta-adrenergics INC Ca in cytosol and SR (via upregulation of cAMP)
- NOTE: can tx SYM overactivity in mitral prolapse
Amiodarone (Class III)
- Action: K+ channel blockade; secondary Na+, Ca+ channel blockade and B-adrenergic blocking
- Use: atrial, ventricular arrhythmias (esp. life-threatening, i.e., vtac, vfib, cardiac resuscitation)
- Side effects: pulm fibrosis (worst), photosensitivity derm, corneal microdeposits, hypo/hyperthyroidism, prox muscle weakness, hepatitis (monitor LFT’s)
- Metabolism/prep: IV/oral; slow elim b/c accumulates in fat tissue (CYP3A4)
What is Wolff Parkinson White syndrome?
- Congenital direct connection b/t atrium and ventricle, called accessory pathways or bypass tracts
1. Allow impulses from the atria to be conducted directly to ventricle as well as through AVN - Asymetric activation of ventricle via this bypass tract reflected on ECG by short PR interval and delta wave
- Bypass tract allows for rapid conduction of impulses to ventricle during atrial arrhythmias, which can induce vfib; also allows reentry b/t bypass tract and AVN, leading to rapid SV tachys
- Definitive tx for pts w/arrhythmias in WPW is to interrupt circuit by radiofrequency catheter ablation of bypass tract
What are the mechanisms of arrhythmias?
- Abnormal impulse generation (automaticity) or abnormal impulse propagation (re-entry)
- Specific mechanisms: (1) enhanced normal automaticity, (2) enhanced abnormal automaticity, (3) triggered automaticity, (4) re-entry (organized or disorganized)
- Aim of therapy of arrhythmias is to reduce ectopic pacemaker activity and modify conduction or refractoriness in re-entry circuits to prevent re-entry
Vtach in pt with coronary disease. 57-y/o WM with chest pain and palpitations. Cardiac enzymes elevated and ECG confirms acute non-ST MI. Admitted to CCU, where telemetry shows runs of monomorphic vtach.
Mechanism and treatment?
- Organized reentry via premature ventricular beat (monomorphic vtach, unlike torsade)
- Amiodarone, Lidocaine, Procaineamide
- NOT Fleconide
How is automaticity influenced by the ANS?
- SA/AV nodes innervated by ANS (no vagal innervation below AV node)
- Rate of phase IV depolarization:
1. INC by SYM stimulation (NE)
2. DEC by vagal stimulation (Ach);also hyperpolarizes SA/AV node cells
3. DEC by action of adenosine receptors - Primary effect of these influences on AV node is to modify conduction of impulses
- Ca channel blockers reduce rate of firing of SA/AV node conduction by reducing depolarization due to Ca influx
Paroxysmal supraventricular tachycardia. Narrow QRS, regular activation, no identifiable atrial activity (p wave) preceding QRS.
Mechanism and treatment?
- P wave buried, but would be inverted if seen; AV node bc narrow QRS
- Adenosine, Verapamil, Esmolol, Digoxin